(Press-News.org) Dr. Amar Kishan, professor and executive vice chair of radiation oncology at the David Geffen School of Medicine at UCLA and co-director of the cancer molecular imaging, nanotechnology and theranostics program at the UCLA Health Jonsson Comprehensive Cancer Center, has been named the recipient of the 2025 Steven A. Leibel Memorial Award, one of the most distinguished honors in radiation oncology.
Presented by the American Society for Radiation Oncology (ASTRO) and the American Board of Radiology (ABR) Foundation, the award recognizes outstanding principal investigators within the first decade of their careers following board certification. Kishan was selected for his pioneering research and leadership in advancing radiation treatments for cancers of the genitourinary system, particularly prostate and bladder cancers.
“This award is a tremendous honor, and I am grateful to ASTRO and the ABR Foundation for this recognition,” said Kishan. “It has been a distinct honor and privilege to spend the past eight years on faculty at UCLA building a robust clinical and translational research program.”
Kishan, who oversees clinical and translational research and is the chief of the genitourinary oncology service, is internationally recognized for his expertise in advanced radiation techniques, including stereotactic body radiotherapy (SBRT) and MRI-guided radiation therapy. He has led multiple landmark clinical trials, including the MIRAGE study, the LUNAR trial, and the newly launched HEATWAVE trial. In addition, he has published more than 310 peer-reviewed manuscripts in leading journals such as JAMA, The Lancet Oncology, and the Journal of Clinical Oncology.
He also leads an active translational research program focused on improving outcomes for patients with prostate cancer, with an emphasis on both enhancing treatment effectiveness and reducing side effects after therapy.
His work has been supported by the National Institutes of Health, Department of Defense, Prostate Cancer Foundation, and other leading organizations. In recognition of his compassionate care and mentorship, Dr. Kishan has also received the Leonard Tow Humanism in Medicine Award (2021) and the UCLA Exceptional Physician Award (2024).
“Dr. Kishan’s leadership, scientific rigor, and commitment to improving outcomes for patients with prostate and bladder cancers exemplify UCLA’s mission to drive innovation in cancer research and care,” said Dr. Michael Steinberg, professor and chair of radiation oncology at the David Geffen School of Medicine at UCLA and director of Clinical Affairs at the UCLA Health Jonsson Comprehensive Cancer Center. “We are proud to see him recognized with this prestigious national honor.”
END
Dr. Amar Kishan honored with Steven A. Leibel Memorial Award
2025-09-29
ELSE PRESS RELEASES FROM THIS DATE:
Europe's oldest blue pigment found in Germany
2025-09-29
At the Final Palaeolithic site of Mühlheim-Dietesheim, Germany, archaeologists from Aarhus University found traces of a blue residue on a stone artifact dating back around 13,000 years. Using a suite of cutting-edge scientific analyses, they confirmed the traces were from the vivid blue mineral pigment azurite, previously unseen in Europe’s Palaeolithic art.
“This challenges what we thought we knew about Palaeolithic pigment use”, sais Dr. Izzy Wisher, the lead author of the study.
Until now, scholars believed Palaeolithic artists predominantly used red and black pigments – practically no other colours ...
New study links genetic variation to chemotherapy-related liver damage in patients with colorectal cancer liver metastases
2025-09-29
ROCHESTER, Minn. — A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe liver damage after chemotherapy.
For patients with colorectal liver metastases, surgery offers the best chance of long-term survival. To improve outcomes, many patients receive chemotherapy before surgery. While this approach can shrink tumors to make them more operable, one potential side effect is injury to the liver. Until now, it hasn't been clear why certain patients' livers are more ...
Daydreaming can lead to epiphanies, greater career purpose, WashU research finds
2025-09-29
The legendary tale of the business leader who had an epiphany that fundamentally changed his or her professional journey — turning hobbies, small observations or frustrations into billion-dollar ideas — is well known. Julia Child writing her first cookbook at 50 and becoming a famous chef; Sara Blakely channeling frustration with undergarments to develop Spanx; Jeff Bezos leaving a successful Wall Street investment career to get in on the booming growth of the internet … the list goes on.
Epiphanies — sudden realizations that transform how people see ...
High pollen count: The last straw effect on suicide risk
2025-09-29
Images
Beyond the sneezing and itchy eyes, high pollen seasons are now linked to a significant increase in suicide risk.
A new University of Michigan study found a 7.4% jump in deaths, suggesting the physical discomfort of allergies may trigger a deeper, more dangerous despair, an overlooked factor in suicide prevention.
The study indicates that allergies' physiological effects, such as poor sleep and mental distress, may contribute to this increased risk.
"A small shock could have a big effect ...
Physicists tighten the net on elusive dark matter
2025-09-29
Determining the nature of dark matter, the invisible substance that makes up most of the mass in our universe, is one of the greatest puzzles in physics. New results from the world’s most sensitive dark matter detector, LUX-ZEPLIN (LZ), have narrowed down the possibilities for one of the leading dark matter candidates: weakly interacting massive particles (WIMPs).
“While we always hope to discover a new particle, it is important for particle physics that we are able to set bounds on what the dark matter might actually be,” said UC Santa Barbara experimental ...
Laboratory breakthrough recreating star formation mechanism wins prestigious John Dawson Award
2025-09-29
Groundbreaking scientific findings on how swirling matter can form stars, planets and supermassive black holes earned a team of scientists from the U.S. Department of Energy’s (DOE) Princeton Plasma Physics Laboratory (PPPL) and Princeton University the 2025 John Dawson Award for Excellence in Plasma Physics Research from the American Physical Society (APS).
The winning team includes Fatima Ebrahimi, Erik Gilson, Hantao Ji and Yin Wang, as well as Princeton University’s Jeremy ...
New one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond
2025-09-29
A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human papillomavirus (HPV) test that delivers results in less than an hour with no specialized laboratory required. The breakthrough could provide an option for women in low-resource settings to be screened and treated for cervical cancer in a single clinic visit, a step that global health experts say could save countless lives. The research was recently published in Nature Communications.
Cervical cancer is considered easily preventable, yet ...
Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability
2025-09-29
INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version of The LOINC Ontology: A LOINC and SNOMED CT Interoperability Solution and a significant advance in their ongoing collaboration to streamline the exchange and use of health data worldwide.
This version expands the Ontology with approximately 6,000 additional concepts, with more than 2,500 new “Orderable Grouper” concepts that provide practical, higher-level groupings for laboratory orders. By introducing this organization, ...
Cornell launches initiative to unravel the science of menopause
2025-09-29
ITHACA, N.Y. -- Two centuries ago, few women lived long enough to reach menopause. Today, it marks a major inflection point in women’s health, yet remains poorly understood. Cornell researchers aim to change that.
Drawing on cutting-edge technology and interdisciplinary expertise, researchers are launching Menopause Health Engineering, a new initiative uniting faculty from Cornell’s Ithaca campus and Weill Cornell Medicine, to uncover how menopause shapes health and disease, and to develop urgently needed treatment ...
Reform of federal drug discount program should target misaligned incentives
2025-09-29
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting healthcare providers.
Congress created the 340B Drug Pricing Program over 30 years ago to help hospitals and clinics that serve high levels of uninsured patients purchase outpatient drugs from manufacturers at significantly discounted prices. However, the law does not require participating providers to pass on discounts to patients or dedicate program funds to safety-net care.
A new white paper from the USC Schaeffer Center for Health Policy & Economics traces how major eligibility expansions and distorted program incentives ...